News
Waiving screening copayments could cut colorectal cancer deaths
CHICAGO – Out-of-pocket costs may present a barrier to colorectal screening, and removing those costs could reduce colorectal cancer deaths,...
News
Exhaustive leveling needed for diagnosis of colon adenomas
Adenomas are too often missed, “partially because pathologists are not typically evaluating an entire specimen.”
News
Gastrointestinal healing in treated celiac patients can vary
CHICAGO – Gluten-free may not be freeing for many recovering patients.
News
Waiving screening copayments could cut colorectal cancer deaths
CHICAGO – Would waiving out-of-pocket costs for colorectal cancer screening be cost effective?
News
Infliximab biosimilar noninferior to originator in IBD – NOR-SWITCH
CHICAGO – Can use of biosimilars save money for IBD patients and health care systems?
News
IL-2 and IL-8 elevated after gluten ingestion on gluten-free diet
CHICAGO – Can serum cytokines after a gluten challenge diagnose celiac disease?
News
Misoprostol effective in healing aspirin-induced small bowel bleeding
Misoprostol was more effective than placebo in healing small bowel ulcers in patients who used daily low-dose aspirin.
News
CRC in Lynch syndrome is lower than previously reported
Careful screening of individuals with Lynch syndrome that includes removal of precancerous polyps may keep colorectal cancer rates down.
News
Anti-TNF drugs reduce mortality in Crohn’s disease
CHICAGO – As compared to prolonged use of corticosteroids, the use of anti-TNF drugs was associated with reduced mortality in patients with Crohn’...
News
Novel agent varlilumab shows activity in RCC
A total of eight patients achieved stable disease in the phase I study, including four with RCC.
News
High CD86+pDC counts may predict CML relapses
High CD86+pDC counts predicted relapses in chronic myeloid leukemia patients who stopped TKI therapy.
News
Neoadjuvant therapy timing may impact pancreatic cancer outcomes
SEATTLE – Delay between neoadjuvant therapy and surgery may offer some benefit to patients with pancreatic cancer.
News
NET can benefit breast cancer patients with delayed surgery
For breast cancer patients whose surgery is delayed, a course of neoadjuvant therapy may be beneficial, but the effectiveness depends on the...
News
Atezolizumab improved survival in triple-negative breast cancer
In a phase I trial, the immunotherapy agent atezolizumab improved survival in triple-negative breast cancer.
News
Avelumab produces durable responses in Merkel cell carcinoma
“Avelumab could be an important new agent for patients with Merkel cell carcinoma who have failed prior chemotherapy,” said Dr. Howard L. Kaufman...